A Cancer Breakthrough Near FDA Approval Has a Costly Side Effect 30 minutes ago

A Cancer Breakthrough Near FDA Approval Has a Costly Side Effect 30 minutes ago


A breakthrough cancer therapy that can wipe out leukemia in some deathly ill children and young adults comes with an expensive, long-lasting side effect. Novartis AG and is on the brink of approval after a panel of advisers to the U.S. Food and Drug Administration backed it Wednesday in a 10-0 vote.



from Biotech News